ALPN News and Press, Alpine Immune Sciences Inc. From 04/11/24

2024-04-11 10:04:28 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Well...

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...

Shares of Alpine Immune Sciences, Inc. (NASDAQ: ALPN) traded at a new 52-week high today and are currently trading at $64.25. So far today, approximately 16.44M shares have been exchanged, as compared to an average 30-day volume of 1.63M shares. Alpine Immune Sciences, Inc., a clinical-stage ...

2024-04-11 09:40:22 ET Summary Boston-based pharma giant Vertex Pharmaceuticais set to acquire Seattle-based biotech company Alpine Immune Sciences for $4.9 billion in cash. The acquisition was unanimously approved by both companies' boards of directors and is expected to close la...

2024-04-11 09:23:46 ET Alpine Immune Sciences Inc (NASDAQ: ALPN) is up 35% on Thursday after Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) said it will acquire the biotechnology company for $65 per share. Is Alpine Immune stock fairly valued at $65? But shareholders of the ...

2024-04-11 08:36:33 ET More on Alpine Immune Sciences Alpine Immune Sciences, Inc. (ALPN) Q4 2023 Earnings Call Transcript Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug Vertex enters into agreement to acquire Alpine Immune Sciences ...

2024-04-11 01:00:03 ET Michael Ulz from Morgan Stanley issued a price target of $65.00 for ALPN on 2024-04-11 00:12:00. The adjusted price target was set to $65.00. At the time of the announcement, ALPN was trading at $47.04. The overall price target consensus is at $48....

2024-04-10 17:20:42 ET Gainers: Rallybio Corporation ( RLYB ) +42% . Alpine Immune Sciences ( ALPN ) +36% . Vera Therapeutics ( VERA ) +10% . Relay Therapeutics ( RLAY ) +7% . Olema Pharmaceuticals  ( OLMA ) +5% . Lose...

A look at the top 10 most actives in the United States Marin Software Incorporated (MRIN) rose 126.3% to $0.6497 on volume of 228,672,822 shares PROSHARES TRUST (SQQQ) rose 2.7% to $10.9 on volume of 177,760,238 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 4.9% to $3.43 ...

-- Povetacicept administered subcutaneously once every four weeks continues to be well tolerated in IgA nephropathy, with UPCR reductions of greater than 60% observed at 36 weeks, associated with remission, resolution of hematuria, and stable renal function (eGFR) -- -- Company reports ...